Erythropoeitin effect on Chronic Kidney Disease

Effect of erythropoietin on glomerular filtration rate in patients with chronic kidney disease with mild anemia in diabetic nephropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016043027686N1

Enrollment

Registered

2016-06-04

Start date

2015-01-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease. Kidney damage with mild decreased GFR (60-89 mL/min)

Interventions

Intervention 1: Treatment group: Erythropoeitin 25U/Kg every other day. Intervention 2: Control group: no drugs.

Treatment - Drugs

Treatment group: Erythropoeitin 25U/Kg every other day

Control group: no drugs

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with stage II CKD Exclusion criteria: Anemia due to another disease except CKD; History of secondary hyperthyroidism; Malignancies

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Glomerular Filtration Rate. Timepoint: Before intervention, after intervention with 2 months intervals till 6 months. Method of measurement: Using Formula.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Khalili Sadrabad

Zahedan University of Medical Sciences

m.khalili@zaums.ac.ir+98 35 3235 3222

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026